{
  "id": "518cb513310faafe08000007",
  "type": "summary",
  "question": "What is the treatment of amiodarone-induced thyrotoxicosis?",
  "ideal_answer": "Treatment of amiodarone-induced thyrotoxicosis is complex and may include drugs such as antithyroid drugs, beta-blockers, corticosteroids lithium as well as iopanoic acid in preparation of thyroidectomy. Total thyroidectomy and radioiodine represent alternative treatment options",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/22130792",
    "http://www.ncbi.nlm.nih.gov/pubmed/19109209",
    "http://www.ncbi.nlm.nih.gov/pubmed/20583541",
    "http://www.ncbi.nlm.nih.gov/pubmed/19105148",
    "http://www.ncbi.nlm.nih.gov/pubmed/22386340",
    "http://www.ncbi.nlm.nih.gov/pubmed/19675515",
    "http://www.ncbi.nlm.nih.gov/pubmed/18410546",
    "http://www.ncbi.nlm.nih.gov/pubmed/21865355",
    "http://www.ncbi.nlm.nih.gov/pubmed/22865896",
    "http://www.ncbi.nlm.nih.gov/pubmed/21225109",
    "http://www.ncbi.nlm.nih.gov/pubmed/18595575",
    "http://www.ncbi.nlm.nih.gov/pubmed/18421194",
    "http://www.ncbi.nlm.nih.gov/pubmed/19622616"
  ],
  "snippets": [
    {
      "text": "Prednisone remains the preferred treatment modality of AIT type 2, because perchlorate given alone or in combination with prednisone had no better outcomes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22130792",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Total thyroidectomy, by rapidly restoring euthyroidism, may improve cardiac function and reduce the risk of mortality in AIT patients with severe LV dysfunction.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22865896",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Prednisone restores euthyroidism in most type 2 AIT patients, irrespective of amiodarone continuation or withdrawal. However, continuing amiodarone increases the recurrence rate of thyrotoxicosis, causing a delay in the stable restoration of euthyroidism and a longer exposure of the heart to thyroid hormone excess.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21865355",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Steroid therapy should be started when findings indicate type II or mixed-type AIT. Beta blockers may prevent heart thyrotoxicosis and recurrence of primary arrhythmia if amiodarone is discontinued.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20583541",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Glucocorticoids are the first-line treatment in type 2 AIT, whereas thionamides play no role in this destructive thyroiditis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19622616",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "iopanoic can be used to rapidly lower FT(3) levels and to treat symptoms of thyrotoxicosis in a preoperative setting.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19105148",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The patient responded to iopanoic acid with a rapid decrease in his FT(3) level and slight increase in his FT(4) level.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19105148",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "In patients with type-2 AIT, RAI treatment may be the therapy of choice for thyroid gland ablation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18595575",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "In type 1 AIT thionamides represent the treatment of choice for North Americans as well as for Europeans,",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18410546",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Glucocorticoids are the selected treatment for type 2 AIT, alone (62%vs. 46% in Europe, P < 0.05) or in association with thionamides",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18410546",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "After restoration of euthyroidism, thyroid ablation in the absence of recurrent thyrotoxicosis is recommended in type 1 AIT less frequently by North Americans.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18410546",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    }
  ],
  "concepts": []
}